Literature DB >> 2466458

Mutagenesis of human granulocyte colony stimulating factor.

T Kuga1, Y Komatsu, M Yamasaki, S Sekine, H Miyaji, T Nishi, M Sato, Y Yokoo, M Asano, M Okabe.   

Abstract

To define the structure-function relationship, we have made a number of mutants of human granulocyte colony-stimulating factor (hG-CSF) by in vitro mutagenesis. The results indicate that most of the mutations located in the internal and C-terminal regions of the molecule abolished the activity, whereas the mutants without N-terminal 4, 5, 7, or 11 amino acids retained the activity. N-terminal amino acids were also altered by cassette mutagenesis using a synthetic oligonucleotide mixture. Among them, KW2228, in which Thr-1, Leu-3, Gly-4, Pro-5 and Cys-17 were respectively substituted with Ala, Thr, Tyr, Arg and Ser, showed more potent granulopoietic activity than that of intact hG-CSF both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2466458     DOI: 10.1016/0006-291x(89)92410-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Production of recombinant granulocyte colony-stimulating factor by knocking into the active immunoglobulin heavy chain gene locus in the hybridoma cell line.

Authors:  Y Kuwana; K Funayama; H Miyaji; M Hasegawa; H Yoshida; S Itoh
Journal:  Cytotechnology       Date:  2001-11       Impact factor: 2.058

2.  Conformational changes of recombinant human granulocyte-colony stimulating factor induced by pH and guanidine hydrochloride.

Authors:  L O Narhi; W C Kenney; T Arakawa
Journal:  J Protein Chem       Date:  1991-08

3.  Site-Specific Protein PEGylation: Application to Cysteine Analogs of Recombinant Human Granulocyte Colony-Stimulating Factor.

Authors:  Mary S Rosendahl; Daniel H Doherty; Darin J Smith; Alison M Bendele; George N Cox
Journal:  Bioprocess Int       Date:  2005-04

Review 4.  Activating mechanism of CNTF and related cytokines.

Authors:  M Inoue; C Nakayama; H Noguchi
Journal:  Mol Neurobiol       Date:  1996-06       Impact factor: 5.590

5.  Expression of recombinant human mutant granulocyte colony stimulating factor (Nartograstim) in Escherichia coli.

Authors:  F R Gomes; A C Maluenda; J O Tápias; F L S Oliveira; L C Sá-Rocha; E Carvalho; P L Ho
Journal:  World J Microbiol Biotechnol       Date:  2012-05-01       Impact factor: 3.312

6.  Characterization of the receptor binding determinants of granulocyte colony stimulating factor.

Authors:  D C Young; H Zhan; Q L Cheng; J Hou; D J Matthews
Journal:  Protein Sci       Date:  1997-06       Impact factor: 6.725

7.  Renal clearance of a recombinant granulocyte colony-stimulating factor, nartograstim, in rats.

Authors:  T Kuwabara; Y Ishikawa; H Kobayashi; S Kobayashi; Y Sugiyama
Journal:  Pharm Res       Date:  1995-10       Impact factor: 4.200

8.  Structure-function studies of human ciliary neurotrophic factor.

Authors:  A Negro; V Corsa; G Corona; C Grandi; S D Skaper; L Callegaro
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

9.  Characterization of two fluorescent tryptophans in recombinant human granulocyte-colony stimulating factor: comparison of native sequence protein and tryptophan-deficient mutants.

Authors:  C G Kolvenbach; S Elliott; R Sachdev; T Arakawa; L O Narhi
Journal:  J Protein Chem       Date:  1993-04

10.  Process development for production of human granulocyte-colony stimulating factor by high cell density cultivation of recombinant Escherichia coli.

Authors:  Rasoul Khalilzadeh; Jafar Mohammadian-Mosaabadi; Ali Bahrami; Ahmad Nazak-Tabbar; Mohammad Ali Nasiri-Khalili; Alireza Amouheidari
Journal:  J Ind Microbiol Biotechnol       Date:  2008-08-06       Impact factor: 3.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.